ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion

doi:10.1016/j.devcel.2023.03.014

. 2023 May 22;58(10):866-884.e8.

doi: 10.1016/j.devcel.2023.03.014. Epub 2023 Apr 12.

ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion

Affiliations

¹ Autophagy, Inflammation and Metabolism Center of Biochemical Research Excellence, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA; Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA.
² Proteomics Core Facility, UC Davis Genome Center, University of California, Davis, Davis, CA 95616, USA.
³ Autophagy, Inflammation and Metabolism Center of Biochemical Research Excellence, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA; Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA. Electronic address: vderetic@salud.unm.edu.

PMID: 37054706
PMCID: PMC10205698
DOI: 10.1016/j.devcel.2023.03.014

ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion

Fulong Wang et al. Dev Cell. 2023.

. 2023 May 22;58(10):866-884.e8.

doi: 10.1016/j.devcel.2023.03.014. Epub 2023 Apr 12.

Authors

Affiliations

¹ Autophagy, Inflammation and Metabolism Center of Biochemical Research Excellence, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA; Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA.
² Proteomics Core Facility, UC Davis Genome Center, University of California, Davis, Davis, CA 95616, USA.
³ Autophagy, Inflammation and Metabolism Center of Biochemical Research Excellence, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA; Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131, USA. Electronic address: vderetic@salud.unm.edu.

PMID: 37054706
PMCID: PMC10205698
DOI: 10.1016/j.devcel.2023.03.014

Abstract

ATG5 is a part of the E3 ligase directing lipidation of ATG8 proteins, a process central to membrane atg8ylation and canonical autophagy. Loss of Atg5 in myeloid cells causes early mortality in murine models of tuberculosis. This in vivo phenotype is specific to ATG5. Here, we show using human cell lines that absence of ATG5, but not of other ATGs directing canonical autophagy, promotes lysosomal exocytosis and secretion of extracellular vesicles and, in murine Atg5^fl/fl LysM-Cre neutrophils, their excessive degranulation. This is due to lysosomal disrepair in ATG5 knockout cells and the sequestration by an alternative conjugation complex, ATG12-ATG3, of ESCRT protein ALIX, which acts in membrane repair and exosome secretion. These findings reveal a previously undescribed function of ATG5 in its host-protective role in murine experimental models of tuberculosis and emphasize the significance of the branching aspects of the atg8ylation conjugation cascade beyond the canonical autophagy.

Keywords: ATG5; ESCRT; SARS-CoV-2; atg8ylation; autophagy; coronavirus; exosomes; lysosome; neutrophils; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Figures

**Figure 1.. Loss of ATG5 but not of other ATGs renders lysosomes excessively susceptible to damage**
A, Survival curves (mice) post aerosol challenge with Mtb (Erdman; initial lung deposition of 305 CFU). Log-rank (Montel-Cox) test. B, Quantification and C, representative images of LysoTracker Red (LTR) puncta in bone marrow derived macrophage (BMMs) isolated from Atg5^fl/fl LysM-Cre⁻, Atg5^fl/fl LysM-Cre⁺, Atg7^fl/fl LysM-Cre⁻, Atg7^fl/fl LysM-Cre⁺ mice treated with 2 mM of LLOMe for 1 h using High Content Microscopy (HCM). Data, means ± SE (n≥4); unpaired t-test. Each data point represents independent biological replicates with BMMs from different animals. D, HCM quantification of LTR in BMMs subjected to CRISPR inactivation of Atg5 gene (Atg5^{BMM-CRISPR-KO}) compared to Atg5^BMM-WT control guide RNA treated cells. Data, means ± SE (n=3); unpaired t-test. E, Immunoblots, Huh7 and mutant cells. F, HCM quantification and G, representative image of LTR puncta in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated with 1 mM LLOMe for 30 min. Data, means ± SE (n=5); two-way ANOVA with Tukey’s multiple comparisons. Inset, ratio of LTR puncta in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated:untreated with LLOMe. H, HCM quantification of LAMP2 puncta in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated with 1 mM LLOMe for 30 min. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. I, HCM quantification of LTR puncta in HeLa (2 mM LLOMe, 30 min), A549 and U2OS (1 mM LLOMe, 30 min) and mutant cells. Data, means ± SE (n=5); unpaired t-test. J, HCM quantification of LTR puncta in Huh7 and mutant (1 mM LLOMe, 30 min). Data, means ± SE (n=4); one-way ANOVA with Tukey’s multiple comparisons. K, HCM quantification of Gal3 puncta in cell lines and under conditions as in panel I. Data, means ± SE (n=6); two-way ANOVA with Tukey’s multiple comparisons. L, HCM quantification of Gal3 puncta in BMMs from Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ mice treated with 2 mM LLOMe for 1 h. Data, means ± SE (n=4); two-way ANOVA with Tukey’s multiple comparisons. Each point represents independent biological replicate from BMMs derived from bone marrows of different animals. M, Immunoblot (top) and HCM quantification (bottom) of Gal3 puncta in PaTu-8902^WT and PaTu-8902^ATG5-KO cells treated or not with 1.5 mM LLOMe for 30 min. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. N, HCM quantification of Gal3 puncta in HeLa^ATG5-WT and HeLa^ATG5-KO cells treated with silica. Data, means ± SE (n=6); unpaired t-test. O, HCM quantification of Gal3 puncta in A549^ATG5-WTand A549^ATG5-KO cells overexpressing mCherry or mCherry-ORF3a^SARS-CoV-2. Data, means ± SE (n=5); two-way ANOVA with Tukey’s multiple comparisons. P, HCM quantification and representative image of Gal3 puncta in Huh7 and mutant cells (1 mM LLOMe, 30 min). Data, means ± SE (n=4); One-way ANOVA with Tukey’s multiple comparisons. Q, Immunoblot of Huh7^WT and Huh7^ATG5-KO cells overexpressing or not overexpressing mCherry-ATG5^WT or mCherry-ATG5^K130R. R, HCM quantification and S, representative image of Gal3 puncta in HeLa^ATG5-WT and HeLa^ATG5-KO cells control or transfected with mCherry-ATG5^WT or mCherry-ATG5^K130R (2 mM LLOMe, 30 min). Data, means ± SE (n=3); unpaired t-test. T, Summary of the findings in Figure 1. In all HCM graphs, each individual data point represents independent biological replicate, with values based on 49–64 fields/well, >500 primary objects (cells) per well, 5 wells per sample (used only for sampling error) with bars denoting the mean for the biological replicates and standard errors of the mean. Statistical significance symbols in all panels, †p≥0.05, *p<0.05, **p<0.01.

**Figure 2.. ATG5 is required for recruitment of ESCRTs to repair damaged lysosomes**
A, Representative confocal images of ALIX and LAMP1 staining in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated with 1 mM LLOMe for 30 min. Scale bars, 10 μm. **B&C,** HCM quantification of ALIX puncta and ALIX-LAMP1 overlap in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated with or without 1 mM LLOMe for 30 min. Data, means ± SE (n=4); two-way ANOVA with Tukey’s multiple comparisons. **D&E,** HCM quantification of CHMP4B-LAMP2 overlap and CHMP4B-LAMP2 overlap in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated as panel B. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. F, HCM quantification of ALIX puncta and ALIX-LAMP1 overlap in HeLa^ATG5-WT and HeLa^ATG5-KO cells transfected with mCherry, mCherry-ATG5^WT, or mCherry-ATG5^K130R followed by treatment with or without 2 mM LLOMe for 30 min. Data, means ± SE (n=3); unpaired t-test. G, Representative confocal images and **H&I,** quantification (HCM) of ALIX puncta and ALIX-LAMP1 overlap in Huh7 and mutant cells treated as in panel B. Data, means ± SE (n=3); unpaired t-test. Scale bars, 10 μm. J, Schematic description, K, Immunoblot, and L, quantification of lysosome ESCRT components by anti-HA immunoprecipitation (LysoIP; TMEM192–3xHA) from HeLa^ATG5-WT and HeLa^ATG5-KO cells treated as in panel F. Long exp (long exposure) and Short exp (short exposure) correspond to the same blot. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. M, Summary of the findings in Figure 2. All HCM graphs represent independent biological replicates as in detailed in Figure 1. Statistical significance symbols in all panels, †p≥0.05, *p<0.05, **p<0.01.

**Figure 3. Proximity biotinylation proteomics of ATG5 interactors**
**. A,** (i) Stable FlpIn-HeLa^{APEX2-ATG5-WT} or FlpIn-HeLa^{APEX2-ATG5-K130R} cells were (ii) incubated with or without 2 mM LLOMe in full medium supplemented with 2 μg/mL tetracycline for 30 min. Biotinylated proteins were captured by HA beads and subjected to DIA MS. (iii), conjugation-independent or conjugation-dependent interactors of ATG5 were determined by relative fold change of FlpIn-HeLaAPEX2-ATG5-K130R and FlpIn-HeLaAPEX2-ATG5-WT cells treated with LLOMe compared with FlpIn-HeLa^{APEX2-ATG5-WT} cells without LLOMe incubation. B, Volcano plot of mass spec result of FlpIn-HeLa^{APEX2-ATG5-WT} incubated with or without LLOMe. C, GO terms, pathway enrichment analysis of conjugation-independent proteins.

**Figure 4.. Lysosomal damage induces extracellular vesicle release and neutrophil degranulation**
A, Representative graph of concentration (y-axis), size distribution (x-axis) and B, quantification of EVPs from supernatant of HeLa cells treated with or without 2 mM LLOMe for 1 h using nanoparticle tracking analysis (NTA). Data, means ± SE (n=3); unpaired t-test. C, Representative tracing of concentration, size distribution and D, quantification of EVPs from supernatants of HeLa cells expressing mCherry or mCherry-ORF3a (transient transfection for 24 h) using NTA. Data, means ± SE (n=3); unpaired t-test. E, Quantification of CD63⁺ extracellular vesicles from supernatant of HeLa cells treated as in panel A using AMNIS. Data, means ± SE (n=3); unpaired t-test. F, Quantification of CD63⁺ extracellular vesicles from supernatant of HeLa cells transfected with mCherry or mCherry-ORF3a for 42 h using AMNIS. Data, means ± SE (n=3); unpaired t-test. G, Quantification of CD63⁺ extracellular vesicles from supernatants of BMMs treated as in panel A using AMNIS. Data, means ± SE (n=3); unpaired t-test. H, Quantification of EVPs from supernatant of BMNs (murine bone marrow derived neutrophils) treated with or without 1 mM LLOMe for 1 h using NTA. Data, means ± SE (n=3); unpaired t-test. I, Quantification of CD63⁺ extracellular vesicles extracted from supernatant of BMNs treated as in panel H using AMNIS. Data, means ± SE (n=3); unpaired t-test. J, Representative flow cytometry and K, quantification of % CD11b^High Ly6G⁺ BMNs treated with 1 mM LLOMe for 30 min, or 10μg/ml dihydrocytochalasin B for 5 min followed by 10 μM fMLF for 15 min. Data, means ± SE (n=5); one-way ANOVA with Tukey’s multiple comparisons. L, Mean fluorescence intensity (MFI) of CD11b on BMNs treated as in panel J. Data, means ± SE (n=5); one-way ANOVA with Tukey’s multiple comparisons. M, Quantification of elastase activity in supernatant of BMNs treated as in panel J. Data, means ± SE (n=3); one-way ANOVA with Tukey’s multiple comparisons. In all panels, each data point represents independent biological replicate. For BMM and BMN experiments, each point represents independent biological replicates from different animals. Statistical significance symbols in all panels, †p≥0.05, *p<0.05, **p<0.01.

**Figure 5.. ATG5 knockout enhances EV release in response to lysosomal damage**
A, Flow cytometry quantification of CD63⁺ EVs extracted from supernatant of HeLa^ATG5-WT and HeLa^ATG5-KO cells incubated with indicated concentration of LLOMe for 1 h. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. B, Quantification of EVPs extracted from supernatant of HeLa^ATG5-WT and HeLa^ATG5-KO cells treated with or without 2 mM LLOMe for 1 h using NTA. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. C, Immunoblot and quantification of exosomal markers in EVs isolated from supernatant of HeLa^ATG5-WT and HeLa^ATG5-KO cells incubated with 1 mM LLOMe for 1 h. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. D, Immunoblot and quantification of exosomal markers in EVs isolated from supernatant of HeLa^ATG5-WT and HeLa^ATG5-KO cells transfected with mCherry or mCherry-ORF3a for 42 h. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. E, Quantification (NTA) of EVPs from supernatant as in panel D. Data, means ± SE (n=4); two-way ANOVA with Tukey’s multiple comparisons. F, Flow cytometry quantification of CD63⁺ EVs extracted from supernatant as in panel D. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. G, Representative graph of concentration, size distribution and quantification (NTA) of EVPs from supernatant of BMNs from Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ mice incubated with or without 0.5 mM LLOMe for 1 h. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. H, Flow cytometry quantification of CD63⁺ EVs from supernatant as in panel G. Data, means ± SE (n=5); two-way ANOVA with Tukey’s multiple comparisons. I, Flow cytometry quantification of CD63⁺ EVs from supernatant of Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ BMMs incubated with or without 2 mM LLOMe for 1 h. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. For BMM and BMN experiments, each point represents independent biological replicates from different. Statistical significance symbols in all panels, †p≥0.05, *p<0.05, **p<0.01.

**Figure 6.. ATG5 knockout enhances PMN degranulation in response to lysosomal damage**
A, MFI of CD11b on BMNs incubated with 0.5 mM LLOMe for 30 min, or 10μg/ml dihydrocytochalasin B for 5 min followed by 1 μM fMLF for 15 min. Data, means ± SE (n=4–6); two-way ANOVA with Tukey’s multiple comparisons. B, Representative flow cytometry of BMNs and C, quantification of % CD11b^High Ly6G⁺ BMNs from Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ mice incubated with or without 0.5 mM LLOMe for 30 min. Data, means ± SE (n=5–6); two-way ANOVA with Tukey’s multiple comparisons. D, MFI of FPR1 on BMNs treated as in panel C. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. E, Quantification of elastase activity in supernatant of BMNs from Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ mice treated as in panel C. Data, means ± SE (n=4–6); two-way ANOVA with Tukey’s multiple comparisons. F, MFI of LAMP2 on Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ BMNs treated as in panel A. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. G, Representative flow cytometry of LAMP2 intensity from Atg5^fl/fl LysM-Cre⁻ and Atg5^fl/fl LysM-Cre⁺ treated as in panel A. H, HCM quantification and I, representative images of plasma membrane LAMP2 puncta on Huh7^WT, Huh7^ATG3-KO, Huh7^ATG7-KO, and Huh7^ATG5KO cells treated with or without 1 mM LLOMe for 30 min. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. J, HCM quantification and K, representative images of plasma membrane LAMP1 puncta on Huh7 and mutant cells treated with or without 1 mM LLOMe for 30 min. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. L, Representative confocal images and M, quantification of plasma membrane LAMP1 puncta on HeLa^ATG5-WT, and HeLa^ATG5-KO cells treated with or without 2 mM LLOMe for 30 min. Scale bars, 10 μm. Data, means ± SE (n=4); two-way ANOVA with Tukey’s multiple comparisons. Fluorescence intensity was calculated based on ≥20 fields (with a total ≥100 cells) per biological replicate. N. Summary of data in Figure 6. GO (middle panel), ATG5 interactors identified in proteomic analyses. All HCM graphs represent independent biological replicates as in detailed in Figure 1. For BMMs and BMNs experiments, each point represents independent biological replicates with BMNs from different animals. Statistical significance symbols in all panels, †p≥0.05, *p<0.05, **p<0.01.

**Figure 7.. Alternative conjugation contributes to lysosomal vulnerability and exocytic processes**
A, Representative confocal images of Huh7^ATG5-WT and Huh7^ATG5-KO cells incubated with 1 mM LLOMe for 30 min. Scale bars, 5 μm. **B-E,** Representative images (B) and quantifications of ALIX puncta (C), ATG3 puncta (D), and ATG3-ALIX overlap area (E) in Huh7^ATG5-WT and Huh7^ATG5-KO cells treated as panel A. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. F, Representative graphs and G, quantification of EVPs from supernatant of HeLa and mutant cells treated with 2 mM LLOMe for 30 min. Data, means ± SE (n=3); two-way ANOVA with Tukey’s multiple comparisons. Inset: Immunoblot of HeLa and mutant cells. **H-J,** HCM quantification of ALIX puncta (H), ALIX-LAMP1 overlap area (I), and Gal3 puncta (J) in Huh7 and mutant cells treated as in panel A. Data, means ± SE (n≥3); two-way ANOVA with Tukey’s multiple comparisons. K, Summary of the mechanistic findings in Figure 7. All HCM graphs represent independent biological replicates as in detailed in Figure 1. Statistical significance symbols in all panels, †p≥0.05, *p<0.05, **p<0.01.

See this image and copyright information in PMC

Cited by

The Rubicon-WIPI axis regulates exosome biogenesis during ageing.
Yanagawa K, Kuma A, Hamasaki M, Kita S, Yamamuro T, Nishino K, Nakamura S, Omori H, Kaminishi T, Oikawa S, Kato Y, Edahiro R, Kawagoe R, Taniguchi T, Tanaka Y, Shima T, Tabata K, Iwatani M, Bekku N, Hanayama R, Okada Y, Akimoto T, Kosako H, Takahashi A, Shimomura I, Sakata Y, Yoshimori T. Yanagawa K, et al. Nat Cell Biol. 2024 Aug 22. doi: 10.1038/s41556-024-01481-0. Online ahead of print. Nat Cell Biol. 2024. PMID: 39174742
Noncanonical roles of ATG5 and membrane atg8ylation in retromer assembly and function.
Paddar MA, Wang F, Trosdal ES, Hendrix E, He Y, Salemi M, Mudd M, Jia J, Duque TLA, Javed R, Phinney B, Deretic V. Paddar MA, et al. bioRxiv [Preprint]. 2024 Jul 12:2024.07.10.602886. doi: 10.1101/2024.07.10.602886. bioRxiv. 2024. PMID: 39026874 Free PMC article. Preprint.
Atg8/LC3 controls systemic nutrient surplus signaling in flies and humans.
Madan A, Kelly KP, Bahk P, Sullivan CE, Poling ME, Brent AE, Alassaf M, Dubrulle J, Rajan A. Madan A, et al. Curr Biol. 2024 Aug 5;34(15):3327-3341.e9. doi: 10.1016/j.cub.2024.06.005. Epub 2024 Jul 1. Curr Biol. 2024. PMID: 38955177
A mechanism that transduces lysosomal damage signals to stress granule formation for cell survival.
Duran J, Poolsup S, Allers L, Lemus MR, Cheng Q, Pu J, Salemi M, Phinney B, Jia J. Duran J, et al. bioRxiv [Preprint]. 2024 Apr 2:2024.03.29.587368. doi: 10.1101/2024.03.29.587368. bioRxiv. 2024. PMID: 38617306 Free PMC article. Preprint.
Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice.
Feng S, McNehlan ME, Kinsella RL, Sur Chowdhury C, Chavez SM, Naik SK, McKee SR, Van Winkle JA, Dubey N, Samuels A, Swain A, Cui X, Hendrix SV, Woodson R, Kreamalmeyer D, Smirnov A, Artyomov MN, Virgin HW, Wang YT, Stallings CL. Feng S, et al. Nat Microbiol. 2024 Mar;9(3):684-697. doi: 10.1038/s41564-024-01608-x. Epub 2024 Feb 27. Nat Microbiol. 2024. PMID: 38413834

See all "Cited by" articles

References

1. Mizushima N, Levine B, Cuervo AM, and Klionsky DJ (2008). Autophagy fights disease through cellular self-digestion. Nature 451, 1069–1075. - PMC - PubMed
1. Morishita H, and Mizushima N (2019). Diverse Cellular Roles of Autophagy. Annu Rev Cell Dev Biol 35, 453–475. 10.1146/annurev-cellbio-100818-125300. - DOI - PubMed
1. Levine B, and Kroemer G (2019). Biological Functions of Autophagy Genes: A Disease Perspective. Cell 176, 11–42. 10.1016/j.cell.2018.09.048. - DOI - PMC - PubMed
1. Galluzzi L, and Green DR (2019). Autophagy-Independent Functions of the Autophagy Machinery. Cell 177, 1682–1699. 10.1016/j.cell.2019.05.026. - DOI - PMC - PubMed
1. Deretic V, and Lazarou M (2022). A guide to membrane atg8ylation and autophagy with reflections on immunity. J Cell Biol 221. 10.1083/jcb.202203083. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- Mouse Genome Informatics (MGI)
Miscellaneous
- NCI CPTAC Assay Portal

[1] Mizushima N, Levine B, Cuervo AM, and Klionsky DJ (2008). Autophagy fights disease through cellular self-digestion. Nature 451, 1069–1075. - PMC - PubMed

[2] Mizushima N, Levine B, Cuervo AM, and Klionsky DJ (2008). Autophagy fights disease through cellular self-digestion. Nature 451, 1069–1075. - PMC - PubMed

[3] Morishita H, and Mizushima N (2019). Diverse Cellular Roles of Autophagy. Annu Rev Cell Dev Biol 35, 453–475. 10.1146/annurev-cellbio-100818-125300. - DOI - PubMed

[4] Morishita H, and Mizushima N (2019). Diverse Cellular Roles of Autophagy. Annu Rev Cell Dev Biol 35, 453–475. 10.1146/annurev-cellbio-100818-125300. - DOI - PubMed

[5] Levine B, and Kroemer G (2019). Biological Functions of Autophagy Genes: A Disease Perspective. Cell 176, 11–42. 10.1016/j.cell.2018.09.048. - DOI - PMC - PubMed

[6] Levine B, and Kroemer G (2019). Biological Functions of Autophagy Genes: A Disease Perspective. Cell 176, 11–42. 10.1016/j.cell.2018.09.048. - DOI - PMC - PubMed

[7] Galluzzi L, and Green DR (2019). Autophagy-Independent Functions of the Autophagy Machinery. Cell 177, 1682–1699. 10.1016/j.cell.2019.05.026. - DOI - PMC - PubMed

[8] Galluzzi L, and Green DR (2019). Autophagy-Independent Functions of the Autophagy Machinery. Cell 177, 1682–1699. 10.1016/j.cell.2019.05.026. - DOI - PMC - PubMed

[9] Deretic V, and Lazarou M (2022). A guide to membrane atg8ylation and autophagy with reflections on immunity. J Cell Biol 221. 10.1083/jcb.202203083. - DOI - PMC - PubMed

[10] Deretic V, and Lazarou M (2022). A guide to membrane atg8ylation and autophagy with reflections on immunity. J Cell Biol 221. 10.1083/jcb.202203083. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion

Affiliations

ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Miscellaneous

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Miscellaneous